CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

Clinical trial NCT06708299 · RECRUITING

Trial details

NCT number: NCT06708299
Sponsor: Cardiol Therapeutics Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Pericarditis

Start date: 2025-04-07
Primary completion: 2026-09-21
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.